GLOBAL BIODEFENSE – Ceres Nanosciences Inc. this week announced the commencement of a development program, funded by the Gates Foundation, to use Ceres’ Nanotrap particle technology to develop a new method of detecting the presence of the Ebola virus in saliva. During the four-month performance of this program, Ceres will work in close collaboration with George Mason University and the United States Army Medical Research Institutes of Infectious Diseases (USAMRIID) to assess the ability of the Nanotrap technology to develop a more sensitive and safer Ebola virus detection method that uses saliva instead of blood. Continue